Sangamo Therapeutics Inc and Pfizer Inc said on Wednesday they would work together to develop a gene therapy to treat ALS
Scholar Rock has raised $47 million to take its treatment for spinal muscular atrophy (SMA) into the clinic. The series C tees up Scholar Rock to find out whether its myostatin blocker can best the underwhelming performance of one-time rivals from companies including Novartis.
New drug approvals all but screeched to a halt in 2016, with a measly 22 new OKs after a pair of bountiful years. But the FDA wasted no time in 2017, signing off on 12 drugs in the first quarter alone—besting its record for the same period of any year in recent history.
Recent innovations from global device makers like Abbott to smaller specialists such as Nevro Corp. made the implants more powerful and effective. Combined with a national crackdown on narcotics and wanton pain pill prescriptions, they are spurring demand for implants.
The first portable bionic hand restores the sense of touch in people who lost their limbs. Although the hand is still a prototype, we're one step closer to the day when a fully natural, sensorized prosthesis will be available.
People with chronic obstructive pulmonary disease (COPD) who use long-acting inhaled bronchodilators may have an increased risk of heart attacks and strokes right after they start taking these medicines, a Taiwanese study suggests.
The FDA approved angiotensin-II (Giapreza) as a new intravenous vasopressor for septic shock and other forms of distributive shock. The first new FDA-approved vasopressor in decades, angiotensin-II could significantly change the management of severe septic shock.
The movement within the wearable market is very clear. Demand makes that wearables are becoming less expensive and increasingly commoditized. Just better sensors are now no longer enough. Wearables need to be smarter and more useful. They need to analyze multiple data at once, or so to say, be more holistic. To do so, many wearable makers all over the world are focusing on AI-powered devices.
Digital health made big strides in 2017. With better provider workflows and more integrated core healthcare platforms, healthcare is on the brink of a disruption. As we move into 2018 and the next wave of innovation, here is a look back on the biggest stories that moved the needle in digital health this year.
More women - especially younger women - are testing positive for marijuana use during pregnancy in Northern California, according to a new study. The research letter, published in the Journal of the American Medical Association, analysed the results of urine tests administered during standard prenatal care of 280,000 women enrolled in the Kaiser Permanente Northern California health-care system.
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.